Drug Search Results
More Filters [+]

ASKBIO-009

Alternative Names: askbio-009, askbio009, askbio 009, bax 335, bax-335
Latest Update: 2024-01-31
Latest Update Note: Clinical Trial Update

Product Description

an adeno-associated virus serotype 8 (AAV8)-based FIX Padua gene therapy

Mechanisms of Action: Gene Therapy,FIX

Novel Mechanism: No

Modality: Gene Therapy

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ASKBIO-009

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hemophilia A|Hemophilia B

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

AskBio009-101

P2

Active, not recruiting

Hemophilia B|Hemophilia A

2030-01-17

24%

Recent News Events